All stock lists
Legend Biotech Corp (NASDAQ:LEGN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
20.41
Insider Score
––Not scored
LEGN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
LEGN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 387.50 M | 305.10 M | 306.38 M | 272.33 M | 255.06 M | 195.05 M |
| Revenue Growth (YoY) | 51.93 % | 56.42 % | 64.26 % | 69.99 % | 36.74 % | 107.52 % |
| Cost of Revenue | 137.40 M | 175.90 M | 123.46 M | 115.31 M | 97.99 M | 71.34 M |
| Gross Profit | 250.10 M | 129.20 M | 182.92 M | 157.02 M | 157.07 M | 123.71 M |
| SG&A Expense | 96.40 M | 90.10 M | 101.19 M | 87.33 M | 80.65 M | 72.43 M |
| R&D Expense | 96.00 M | 85.96 M | 101.33 M | 113.15 M | 98.30 M | 101.92 M |
| Operating Expenses | 192.40 M | 179.00 M | 203.52 M | 200.48 M | 178.95 M | 174.36 M |
| Operating Income | 57.70 M | -49.80 M | -20.60 M | -43.45 M | -21.88 M | -50.65 M |
| Pretax Income | 55.50 M | -53.10 M | -19.60 M | -39.07 M | -124.80 M | -99.13 M |
| Tax Provision | 22.30 M | 1.20 M | 11.22 M | 616.00 K | 582.00 K | 1.79 M |
| Net Income | 33.20 M | -54.30 M | -30.82 M | -39.69 M | -125.38 M | -100.92 M |
| EPS (Basic) | 0.18 | -0.30 | -0.17 | -0.21 | -0.68 | -0.55 |
| EPS (Diluted) | 0.18 | -0.30 | -0.17 | -0.22 | -0.68 | -0.55 |
| Shares Outstanding | 187.00 M | 184.73 M | 184.73 M | 180.41 M | 184.14 M | 183.76 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.